INNOBIO Corporation Limited(大连医诺生物股份有限公司)is a leading biotechnology company specializing in the development, production, and global distribution of high-purity nutritional ingredients, functional lipids, carotenoids, and amino acids. Headquartered in Dalian, China, the company serves a diverse customer base in the dietary supplement, functional food, beverage, cosmetics, and animal nutrition sectors worldwide.
Company Background and History
Founded in 2003, INNOBIO has established itself as a science-driven enterprise with a mission to "deliver health through innovation." The company operates under a vertically integrated model that spans R&D, fermentation, extraction, synthesis, formulation, and packaging. INNOBIO has received recognition as a National High-Tech Enterprise and is listed on the NEEQ (National Equities Exchange and Quotations) in China, reflecting its financial transparency and innovation capability.
INNOBIO maintains a state-of-the-art production facility in Dalian and R&D centers that collaborate with top universities and research institutes globally.
Core Business and Product Offerings
INNOBIO's product lines span five key verticals, targeting human health, sports nutrition, and animal nutrition industries:
Product Categories:
-
Amino Acids and Peptides:
- Branched-Chain Amino Acids (BCAAs): L-Leucine, L-Isoleucine, L-Valine
- Essential Amino Acids (EAAs): Multi-functional EAAs for muscle growth and metabolic health
-
Carotenoids:
- Lutein and Lutein Esters
- Meso-Zeaxanthin
- Astaxanthin
- Beta-Carotene
-
Nutritional Lipids:
- Conjugated Linoleic Acid (CLA)
- Medium Chain Triglycerides (MCT)
- Omega-3, Omega-6, Omega-9 formulations
-
Vitamins:
- Vegan Vitamin D3
- Vitamin K2
- Vitamin C, E, and B complex vitamins
-
Animal Nutrition:
- L-Isoleucine (Feed Grade): For swine and poultry growth performance
INNOBIO also offers customized encapsulation technologies such as microencapsulation and liposome formulations for enhanced stability and bioavailability.
Specialization and Core USP
INNOBIO’s unique value proposition lies in its ability to integrate biosynthesis, precision purification, and formulation technologies to deliver high-purity, bioavailable ingredients. Key differentiators include:
- Proprietary encapsulation technologies that protect sensitive bioactives
- Multi-platform manufacturing for both human and animal nutrition
- Strong R&D capabilities focused on clean-label and vegan-friendly solutions
- Brand portfolio catering to specific applications and market segments
Flagship brands include:
- Synnovo™ – Amino acid-based solutions
- DurOmega™ – Stable omega fatty acids
- MariGuard™ – Marine-derived antioxidant compounds
- LocVita™ – Lutein and carotenoid systems
- DuraLipo™ – Functional lipid complexes
Financial Strength and Market Presence
As a publicly listed company on the Chinese NEEQ exchange (ticker: 831319), INNOBIO maintains financial transparency and consistent revenue growth. The company has reported:
- Annual revenue exceeding RMB 300 million in recent fiscal years
- Exports accounting for over 65% of total sales
- Customers in over 40 countries, including the United States, Germany, Japan, South Korea, and Australia
INNOBIO frequently participates in international trade shows such as:
- Vitafoods Europe
- SupplySide West (USA)
- Health Ingredients Japan
- CPhI China
These events have helped build its global customer base across dietary supplement and functional food sectors.
Shipment and Trade Activity
Based on data available from import-export trade platforms:
- Annual international shipments: Over 1,200 tons of finished nutritional ingredients
- Top exported products: Microencapsulated CLA, BCAAs, Lutein Esters, Vegan D3
- Primary markets: North America, EU, Southeast Asia
The company uses both direct shipping and distributor networks to manage international logistics, with adherence to destination-country documentation and compliance.
Target Market
INNOBIO’s primary clients include:
- Dietary supplement manufacturers
- Functional beverage and food companies
- Sports nutrition brands
- Cosmetic and skincare product developers
- Animal feed producers (premium and specialty feeds)
The company tailors its solutions to brand-specific needs, offering formulation customization, white-label services, and regulatory support.
Capabilities and Infrastructure
INNOBIO’s technical and production infrastructure includes:
- GMP-certified production facilities
- Microencapsulation and nano-delivery platforms
- Application labs for testing in beverages, capsules, powders, and softgels
- Annual production capacity exceeding:
- 800 tons of BCAAs
- 600 tons of CLA and functional lipids
- 200 tons of carotenoids
Its advanced QC labs ensure rigorous testing across purity, particle size, bioavailability, and stability metrics.
Certifications and Compliance
INNOBIO products meet global regulatory standards and hold multiple certifications:
- FSSC 22000
- GMP (Good Manufacturing Practice)
- ISO 9001 and ISO 22000
- Halal and Kosher certified
- Non-GMO and Vegan Certifications
- Compliant with USP, EP, JP, and GB pharmacopoeia standards
The company also assists international customers in meeting compliance with FDA (USA), EFSA (EU), and CFDA (China) regulations.
Major Achievements and Industry Role
- First company in China to commercialize vegan-certified Vitamin D3 from natural fermentation
- Awarded “National High-Tech Enterprise” status by the Chinese Ministry of Science and Technology
- Developed patented technology for liposomal astaxanthin, increasing bioavailability by over 3x
- Holds more than 60 domestic and international patents in encapsulation and biosynthesis
- Recognized in Frost & Sullivan’s Global Functional Lipids Market Report as an emerging leader in ingredient innovation
INNOBIO continues to shape the future of health ingredients through deep R&D, clean-label innovation, and global supply reliability, making it a preferred partner in the international nutraceutical and functional ingredient industry.